K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Associate Director - Program Management, Early Pipeline

Program ManagementConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • At least 10 years of relevant project management experience in the biotechnology, pharmaceutical, or life sciences industry.
  • Strong understanding of drug development and how biotechnology functions integrate.
  • Experience managing cross-functional teams and complex projects.
  • Demonstrated project management and interpersonal skills.
  • Strong problem-solving, organizational, analytical, and attention-to-detail skills.
  • Ability to manage multiple priorities in a fast-paced, dynamic environment.
  • Ability to navigate ambiguity and drive clarity.
  • Ability to respond to changing priorities and uncertainty with composure, resilience, and an open mind while embracing change in an evolving environment.
  • Proven record of collaboration and excellent communication.
  • Proficiency with project management tools such as Smartsheet, Microsoft Project, Excel, think-cell, and OnePager.
  • Bachelor’s degree in science, engineering, or a related field.

Responsibilities

  • Support the Program Leader with planning, execution, and delivery of multiple projects across asset development.
  • Collaborate with clinical, regulatory, nonclinical, technical operations, and other cross-functional teams to ensure alignment with company and program objectives.
  • Collaborate with the Program Leader to ensure agenda topics and outputs align with the overall strategic development plan for the program.
  • Develop and own detailed integrated project plans, including goals, deliverables, timelines, and resource requirements.
  • Identify and manage program risks, issues, and dependencies, and proactively implement mitigation strategies.
  • Monitor project progress and provide regular updates to the Program Leader and other stakeholders, ensuring clear communication and transparency.
  • Own program reports and dashboards for executive and other governance teams.

Desired Qualifications

  • Early- to mid-stage drug development experience, prior to end of Phase 2.
  • Demonstrated high learning agility and curiosity, and experience in highly competitive therapeutic areas.
  • An advanced degree.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs